(Circulation. 1999;100:2527.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Vascular Brachytherapy Institute, Cardiovascular Research Foundation (Y.V., R.W., W.-H.K., B.B., M.L.), and Medlantic Research Institute (Y.V.), Washington Hospital Center, and the Department of Radiation Oncology, Washington Hospital Center (R.C.C.), Washington, DC.
Correspondence to Ron Waksman, MD, Vascular Brachytherapy Institute, Cardiovascular Research Foundation, Suite 4B-1, Washington, DC 20010. E-mail rxw8{at}mhg.edu
| Abstract |
|---|
|
|
|---|
-emitters to injured
vessels. The purpose of this study was to examine the effect of
ionizing radiation on the thrombosis rate (TR) of injured porcine
coronary arteries.
Methods and ResultsThirty-four juvenile swine (63
coronary arteries) were subjected to overstretch balloon injury
followed by IR with doses of 0 to 18 Gy of either ß- or
-radiation. Two weeks after treatment, tissue sections were
perfusion-fixed, stained with hematoxylin-eosin and Verhoeffvan
Giesons stain, and analyzed for presence of a thrombus,
thrombus morphology, and neointima formation by
computer-assisted histomorphometry techniques. Although the overall TR
increased dose-dependently from 0 to 18 Gy prescribed dose, luminal
thrombi decreased. Thrombus area also decreased with increasing
radiation dose, whether assessed at the prescription point or at the
luminal surface, which corresponded to decreased intimal area.
Furthermore, luminal thrombi present after IR tended to consist
mostly of fibrin and thus were less organized than in controls.
ConclusionsThese results suggest that IR induces thrombosis but does not necessarily compromise the lumen. Strategies for reducing TR may further decrease intimal area as well as increasing the safety of this therapy.
Key Words: thrombosis radiation restenosis
| Introduction |
|---|
|
|
|---|
Doses of external-beam radiation similar to those used to treat
balloon-injured coronary arteries in animal models result in
increased thrombosis and delayed wound healing.5 6 There
have been anecdotal reports of subacute thrombosis (<30 days) and
late thrombosis (>30 days) after IR despite treatment with
antithrombotic agents in the feasibility clinical
studies.7 This finding is paradoxical, because thrombosis
has been linked to increased neointimal
hyperplasia,1 2 3 whereas IR reduces neointimal
hyperplasia.4 To address this paradox and to study this
phenomenon in detail, we set out to examine the overall thrombosis rate
(TR), the luminal thrombosis rate (LT), the nonluminal thrombosis rate
(NLT), and the thrombus area (TA) after treatment with doses of IR
ranging from 0 to 18 Gy of either ß- or
-radiation prescribed to
the adventitia. These issues were addressed in a retrospective study in
the porcine model of balloon overstretch injury (BI) at 14 days after
treatment. This time point was chosen because previous studies had
shown that the efficacy of catheter-based IR at suppressing intima
formation at this time point persisted to 6 months8 9 and
because the thrombosis observed clinically appeared to be
subacute.7
| Methods |
|---|
|
|
|---|
After placement of an introducer sheath in the right carotid artery by surgical cutdown, each animal received a single dose of heparin (150 U/kg), and coronary angiography was performed and recorded on cine film (Phillips Cardiodiagnost). Coronary overstretch injury was performed with an angioplasty balloon 30% larger than the reference vessel diameter, positioned in the proximal segments of the left anterior descending, left circumflex, and right coronary arteries, and inflated to 10 atm 3 times for 30 seconds in each artery. After the completion of the injury, the angioplasty balloon was withdrawn, a final angiography was performed to assess vessel patency and degree of injury, and the vessels were randomly assigned to radiation or sham treatment. After irradiation, the delivery catheter and the guiding catheters were removed, and the carotid cutdown was repaired. Nitroglycerin ointment (1 inch) was administered topically, and the animals were returned to routine care.
Radiation Procedural Details
After the BI, a closed-end lumen catheter with marker was
positioned over the injured site for use to deliver radiation dose. The
position of the catheter was checked with fluoroscopy to ensure
adequate coverage at both ends of the injured site. The 4 different
radiation sources examined as part of this study were
192Ir ribbon from Best Medical (n=17 arteries),
186/188Re wire from Soreq (n=10 arteries),
90Y wire from Schneider (n=18 arteries), and
133Xe gas balloon from Cook
Cardiology (n=9 arteries). The first 2 were
noncentering
- and ß-sources, respectively, and the remaining 2
were centered ß-sources. Dosimetric calculations were carried out by
use of the TG43 algorithm11 with data generated by Monte
Carlo calculations following TG60 recommendations.12 Dose
prescription points were those used in previous animal studies, 2
mm from source center for 192Ir
ribbon,8 2 mm from source surface for
186/188Re wire,13 1 mm from
balloon surface for 90Y wire,14 and
0.25 mm from balloon surface for 133Xe
gas15 (Table 1
). All
sources were left in the catheter for a period sufficient to deliver
the prescribed doses of 0 to 18 Gy (2 to 20 minutes). In some cases,
the 0-Gy dose was delivered by administration of a dummy wire, and in
others, no wire was administered; no significant quantitative or
qualitative differences in extent of injury or thrombosis were observed
between these 2 types of arteries (data not shown).
|
The doses described above of the various isotopes used in this
study were also recalculated to reflect dose at the luminal surface.
The calculations of luminal dose were different depending on whether
the isotope was delivered via a centering system
(133Xe, 90Y) or a
noncentering system (192Ir,
186/188Re). Essentially, noncentering systems had
maximal and minimal doses, whereas the centering systems did not.
Consequently, we calculated the luminal dose on the basis of the
average of the minimum and maximum doses for
192Ir and 186/188Re and
used a simple multiple for 133Xe and
90Y (Table 1
).
Tissue Analysis Protocol
After an angiogram was obtained under
anesthesia, the animals were killed 14 days after radiation
or placebo treatment by injection of a euthanasia solution (390 mg/mL
pentobarbital sodium, 1% propylene glycol, 29% ethyl alcohol, 2%
benzyl alcohol). The hearts were perfusion-fixed, and the injured
segments were dissected free from the heart. Serial 2- to 3-mm
transverse segments were processed and embedded in paraffin. Cross
sections (4 µm) were stained with hematoxylin and eosin (H&E)
and Verhoeffvan Gieson elastin (VVG) stain. An experienced observer
blinded to the treatment group examined all
histological sections. Each specimen was evaluated for
the presence of thrombus, neointima formation, and
morphological appearance of the cells within the media, adventitia, and
neointima.
Histomorphometric analysis was performed on each segment with evidence of medial fracture. The histopathological features were measured by use of a computerized PC-compatible image analysis program (Optimas 6; Optimas, Inc). VVG-stained sections were magnified at x25, digitized, and stored in a frame-grabber board (DAGE-MTI). Thrombi were identified and designated as luminal or nonluminal (mural), depending on their predominant location in the artery: LTs were those thrombi in which >75% of the thrombus was present in the lumen, whereas NLTs were those thrombi in which >75% of the thrombus was present either between the media and the adventitia or completely in the adventitia. Area measurements were obtained by tracing the thrombus perimeter (TA, mm2), neointima perimeter (intimal area, IA, mm2, defined by the borders of the internal elastic lamina, lumen, media, and external elastic lamina), and external elastic lamina (vessel area, VA, mm2). The total TA was calculated by summing individual TAs. The arc length of the medial fracture (FL), traced through the neointima from one dissected medial end to the other, was used as a measure of the extent of injury. To correct for extent of injury, the ratios IA/FL and TA/FL were calculated. To correct for thrombosis as a function of vessel size, the ratio TA/FL was calculated.
Statistical Methods
Comparisons of TA, IA/FL, TA/VA, and TA/FL between control
and irradiated arteries were made by either 1-way ANOVA with the
Bonferroni correction for groups whose SD of the means was not
statistically different (P>0.05 by Bartletts test) or by
the Kruskall-Wallis test for groups whose SD of the means was
statistically different (P<0.05 by Bartletts test).
Differences in TRs were analyzed by
2
analysis. Statistically significant differences between
treatment groups were considered to be those with
P<0.05.
| Results |
|---|
|
|
|---|
|
Representative photomicrographs from these experiments
are shown in Figure 2
. These
photomicrographs demonstrate typical LT (Figure 2
, A, C, E, and
G) and NLT (Figure 2
, B, D, F, and H) in arteries subjected to
BI alone (Figure 2
, A and B), BI+5 Gy (Figure 2
, C and
D), BI+15 Gy (Figure 2
, E and F), or BI+18 Gy (Figure 2
, G and H), respectively. Most LTs observed at 0 and 5 Gy appeared to be
acute or subacute, consisting of platelet and/or fibrin
deposits that in many cases tended to occlude the vessel by
75%
(Figure 2
, A and C). The insets in these panels demonstrate the
presence of erythrocytes and granulocytes. In contrast, the thrombi
present in arteries treated with 15 or 18 Gy tended to be NLTs
(mural), consisting of a more organized fibrinous layer of thrombus
along the surface of the injured artery (Figure 2
, F and H; see
also insets). As can be surmised from Figure 1
, few LTs were
observed at 15 or 18 Gy, and this is represented in Figure 2
, E and F. Furthermore, the LTs present at 15 and 18 Gy
were immature and consisted mostly of fibrin in a disorganized pattern.
In general, these thrombi were acellular, lacking in monocytes,
lymphocytes, and granulocytes. Angiographic analysis confirmed
the presence of total occlusions as quantified histomorphometrically
(data not shown).
|
TA and IA
The extent of thrombosis has been reported to affect the extent of
restenosis.1 2 3 As can be seen in Figure 3A
, the extent of intimal hyperplasia
measured as IA corrected for medial FL16 decreased in a
radiation dosedependent fashion (P<0.05). These findings
are in agreement with previous results from studies that used both ß-
and
-emitters.4 At the same radiation doses, TA
also decreased in a dose-dependent fashion (Figure 3A
;
P<0.05). A plot of TA versus IA/FL extracted from these
data demonstrated a linear relationship
(r2=1.00; Figure 3B
).
|
It may be argued that analyses based on prescribed dose are not
correct and that in fact the radiation dose to the luminal surface of
the vessel affects thrombosis more directly. The isotopes used in these
studies vary greatly with respect to type of radiation produced (ß
versus
versus a mixture of the two), delivery system
(catheter-based versus balloon-based), and centering versus
noncentering. These variations can contribute to greatly differing
doses at the luminal surface (Table 1
). Accordingly, we
reanalyzed TA as a function of luminal dose. As seen in Figure 4
, we obtained a relationship similar to
that observed with doses calculated at the prescription point.
|
We next compared TR and TA in arteries subjected to BI followed by IR
using isotopes with similar prescription point doses (15 Gy) but with
widely different luminal surface doses (133Xe and
186/188Re) compared with an isotope with a higher
prescription point dose (18 Gy) but a lower luminal surface dose
(90Y; Table 2
). In
addition, sample sizes were nearly identical in all categories. This
analysis demonstrated no significant differences in TR and TA
between arteries treated with 133Xe and
186/188Re (Table 2
), although both groups
exhibited significantly greater TR and significantly lower TA and IA/FL
than did animals receiving 0 Gy (Table 2
). These similar
parameters were observed despite the almost 2-fold
difference in dose at the luminal surface (84 versus 150 Gy).
Furthermore, the highest TR was observed with 18 Gy of
90Y, a dose that corresponds to only 41 Gy at the
luminal surface (Table 1
).
|
Because the vessel size (VA) or extent of injury (indicated by FL) may
affect the degree of thrombosis, we plotted TA/VA (Figure 5A
) or TA/FL (Figure 5B
) as a
function of radiation dose. Both these plots were similar to that
obtained by plotting TA versus radiation dose (Figures 3
and 4
), and both demonstrated statistically significant reduction of
TA/VA or TA/FL as a function of radiation dose.
|
| Discussion |
|---|
|
|
|---|
Previous studies on the vascular effects of external beam radiation have suggested that increased thrombosis is an adverse late healing effect.5 6 Our findings suggest that IR is associated only with increased TR, but the percent of LT decreases with increasing IR. This finding would suggest that the healing response is indeed delayed, especially because mural thrombosis may be a feature of early arterial healing.3 Furthermore, the thrombi present in irradiated arteries tended to be acellular, lacking cells thought to be involved in the healing response to arterial injury (monocytes, lymphocytes, and granulocytes).1 2 3 Decreases in the numbers or functions of macrophages may increase the residence of the thrombus and its components at the injured segment and may delay its organization. Our findings may suggest that the healing of irradiated arteries is delayed, and this may have adverse functional consequences.
However, we also found that TA decreases with increasing IR, whether
the dose is calculated at the prescription point in the adventitia or
at the luminal surface. Likewise, IA/FL decreases with increasing IR,
and plotting IA/FL as a function of TA yielded a perfect correlation
(Figure 3B
). This finding is in agreement with previous reports
of an association between extent of thrombosis (ie, TA) and intimal
hyperplasia.1 2 3
It is well known that the LTs are more important and clinically
relevant in the short term, because they may propagate, leading to
total occlusion, or may dislodge, leading to distal embolization.
Conversely, the organized mural thrombi are not relevant in the short
term but may contribute to the initiation and development of
atherosclerosis and
restenosis.20 21 This has been demonstrated in
humans at the perianastomotic site of coronary bypass surgery,
where new lesions of atherosclerosis form in
30% of
all bypass grafts.22
One intriguing finding of these studies is that TA was more closely
associated with dose at the prescription point in the adventitia than
with luminal surface dose. Table 2
shows that arteries treated
with isotopes that have identical doses at the prescription
point (133Xe and 186/188Re;
15 Gy) exhibit similar TRs despite having received widely different
luminal surface doses. Arteries treated with 90Y,
which was administered at a higher dose at the prescription point (18
Gy), exhibited a higher TR despite having a much lower luminal surface
dose. Furthermore, a comparison of Figures 3
and 4
suggests that a better correlation exists between TA and prescription
point dose as opposed to luminal surface dose. The efficacy and safety
of ß- versus
-radiation have been discussed, especially because of
the rapid dose falloff with ß-sources.4 23 Our findings
suggest that TR and TA may depend more on the radiation dose at the
adventitia than at the luminal surface.
Limitations
This study is subject to several limitations. This was a
retrospective study that combined several isotopes and both ß- and
-emitters. However, there were no statistical differences between
the 2 isotopes 133Xe and
186/188Re with regard to various
parameters of thrombosis and restenosis at the
15-Gy dose, a dose that caused a significant reduction in IA/FL (Table 2
). Another limitation of this study is that the arteries were
analyzed 14 days after injury, and thus it is unknown what
effect IR has on early thrombosis. Nonetheless, these studies suggest
that IR at therapeutic doses does not worsen thrombosis but in fact may
reduce its impact, and they raise the possibility that one of the
mechanisms that underlie the beneficial effect of IR after BI is due to
this reduction of thrombosis.
Conclusions
This study demonstrated an effect of intracoronary
radiation on thrombus formation and thrombus morphology. Higher doses
of radiation were associated with increases in TR, but more often a
nonobstructive NLT rather than an LT. In addition, the morphology of
thrombi in porcine irradiated arteries appeared to be less organized
than the pattern of thrombosis observed in nonirradiated injured
arteries. These changes in TR and thrombus pattern after radiation
therapy may influence the clinical strategy with antiplatelet
therapy in patients undergoing intervention followed by vascular
brachytherapy.
| Acknowledgments |
|---|
Received April 19, 1999; revision received July 16, 1999; accepted July 20, 1999.
| References |
|---|
|
|
|---|
2.
Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy
MA. Role of platelets in smooth muscle cell proliferation and
migration after vascular injury in rat carotid artery. Proc Natl
Acad Sci U S A. 1989;86:84128416.
3. Schwartz RS. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. Am J Cardiol. 1998;81:14E17E.[Medline] [Order article via Infotrieve]
4. Bhargava B, Vodovotz Y, Waksman R. Intracoronary radiation therapy for prevention of restenosis. Indian Heart J. 1998;50(suppl I):120129.
5. Gillette EL, LaRue SM, Gillette SM. Normal tissue tolerance and management of radiation injury. Semin Vet Med Surg (Small Anim). 1995;10:209213.[Medline] [Order article via Infotrieve]
6. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys. 1995;31:12051211.[Medline] [Order article via Infotrieve]
7.
Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez
J, Burger B, Villoria G, Acquatella H, Crocker IR, Seung KB, Liprie SF.
Long-term angiographic and clinical outcome after
percutaneous transluminal coronary angioplasty
and intracoronary radiation therapy in humans.
Circulation. 1997;96:727732.
8.
Waksman R, Robinson KA, Crocker IR, Gravanis MB,
Cipolla GD, King SB III. Endovascular low-dose irradiation inhibits
neointima formation after coronary artery balloon
injury in swine: a possible role for radiation therapy in
restenosis prevention. Circulation. 1995;91:15331539.
9. Weinberger J, Amols H, Ennis RD, Schwartz A, Wiedermann JG, Marboe C. Intracoronary irradiation: dose response for the prevention of restenosis in swine. Int J Radiat Oncol Biol Phys. 1996;36:767775.[Medline] [Order article via Infotrieve]
10.
Waksman R, Robinson KA, Crocker IR, Wang C, Gravanis
MB, Cipolla GD, Hillstead RA, King SB III. Intracoronary
low-dose ß-irradiation inhibits neointima formation
after coronary artery balloon injury in the swine
restenosis model. Circulation. 1995;92:30253031.
11. Nath R, Anderson L, Luxton G, Weaver K, Williamson J, Meigooni A. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys. 1995;22:209234.[Medline] [Order article via Infotrieve]
12. Nath R, Amols H, Coffey C, Jani S, Li Z, Schell M, Soares C, Whiting J, Cole P, Schwartz R. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Task Group No. 60. Med Phys. 1999;26:119152.[Medline] [Order article via Infotrieve]
13. Bhargava B, Waksman R, Vodovotz Y, Chan RC, Collins SD, Seabron R, Pierre A, Lavie E. Intracoronary irradiation with 186/188rhenium following balloon overstretch injury reduces neointima but does not impair vasoreactivity of porcine coronary arteries. J Interventional Cardiol. 1999;12:263270.
14. Waksman R. Endovascular beta radiation in the swine model. In: Waksman R, ed. Vascular Brachytherapy. 2nd ed. Armonk, NY: Futura Publishing Co; 1998:273286.
15. Apple M, Waksman R. Xenon 133 gas-filled balloon. In: Waksman R, ed. Vascular Brachytherapy. Armonk, NY: Futura Publishing Co; 1998:569578.
16. Robinson KA. Pig coronary artery model of post-angioplasty restenosis. In: Waksman R, King SB, Crocker IR, Mould RF, eds. Vascular Brachytherapy. Armonk, NY: Futura Publishing Co; 1996:3040.
17. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol. 1994;23:14911498.[Abstract]
18.
Hehrlein C, Stintz M, Kinscherf R, Schlösser K,
Huttel E, Friedrich L, Fehsenfeld P, Kübler W. Pure
ß-particle-emitting stents inhibit neointima formation in
rabbits. Circulation. 1996;93:641645.
19. Wilcox JN, Waksman R, King SB, Scott NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys. 1996;36:789796.[Medline] [Order article via Infotrieve]
20. Antman EM, Braunwald E. Acute myocardial infarction. In: Braunwald E, ed. Heart Disease. Philadelphia, Pa: WB Saunders, Inc; 1997:11841288.
21. Fuster V, Vestraete M. Hemostasis, thrombosis, fibrinolysis and cardiovascular disease. In: Braunwald E, ed. Heart Disease. Philadelphia, Pa: WB Saunders, Inc; 1997:18091852.
22. Chesebro JH, Clements IP, Fuster V, Elveback LR, Smith HC, Bardsley WT, Frye RL, Holmes DR Jr, Vlietstra RE, Pluth JR, Wallace RB, Puga FJ, Orszulak TA, Piehler JM, Schaff HV, Danielson GK. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med. 1982;307:7378.[Abstract]
23. Amols HI, Zaider M, Weinberger J, Ennis R, Schiff PB, Reinstein LE. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int J Radiat Oncol Biol Phys. 1996;36:913921.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
R. S. Schwartz, N. A. Chronos, and R. Virmani Preclinical restenosis models and drug-eluting stents: Still important, still much to learn J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1373 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Serruys, W. Wijns, G. Sianos, I. de Scheerder, P. A. van den Heuvel, W. Rutsch, H. D. Glogar, C. Macaya, P. H. Materne, S. Veldhof, et al. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: Results of a randomized trial: Beta-radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE) J. Am. Coll. Cardiol., August 4, 2004; 44(3): 528 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cheneau, M. C. John, J. Fournadjiev, R. C. Chan, H.-S. Kim, L. Leborgne, R. Pakala, H. Yazdi, A. E. Ajani, R. Virmani, et al. Time Course of Stent Endothelialization After Intravascular Radiation Therapy in Rabbit Iliac Arteries Circulation, April 29, 2003; 107(16): 2153 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.W. Serruys, G. Sianos, W. van der Giessen, H.J.R.M. Bonnier, P. Urban, W. Wijns, E. Benit, M. Vandormael, R. Dorr, C. Disco, et al. Intracoronary {beta}-radiation to reduce restenosis after balloon angioplasty and stenting. The Beta Radiation In Europe (BRIE) study Eur. Heart J., September 1, 2002; 23(17): 1351 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Le Blanche, M. Bonneau, M. Wassef, M.-T. Farres, L. Gabez, B. Aubert, M. Duriez, B. I. Levy, J.-M. Bigot, and F. Boudghene Histomorphometric Evaluation of 198Au Endovascular Brachytherapy in a Renal Artery Restenosis Model in Rabbits Am. J. Roentgenol., September 1, 2002; 179(3): 611 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Scheinert, V. Strnad, R. Muller, R. Burckhard, S. Ropers, R. Sauer, W.G. Daniel, R. Bonan, and J. Ludwig High-Dose Intravascular {beta}-Radiation After De Novo Stent Implantation Induces Coronary Artery Spasm Circulation, March 26, 2002; 105(12): 1420 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fischell and R. Virmani Intracoronary Brachytherapy in the Porcine Model: A Different Animal Circulation, November 13, 2001; 104(20): 2388 - 2390. [Full Text] [PDF] |
||||
![]() |
P. Wexberg, M. Gottsauner-Wolf, I. Sulzbacher, P. Birner, A. Laggner, and D. Glogar Fatal Late Coronary Thrombosis after Implantation of a Radioactive Stent: Postmortem Angiographic and Histologic Findings—Case Report Radiology, July 1, 2001; 220(1): 142 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Waksman, A. E. Ajani, R. L. White, E. Pinnow, R. Dieble, A. B. Bui, M. Taaffe, L. Gruberg, G. S. Mintz, L. F. Satler, et al. Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary {{gamma}}-Radiation in Patients With In-Stent Restenosis : Washington Radiation for In-Stent Restenosis Trial Plus 6 Months of Clopidogrel (WRIST PLUS) Circulation, May 15, 2001; 103(19): 2332 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kaluza, A. E. Raizner, W. Mazur, D. G. Schulz, J. M. Buergler, L. F. Fajardo, F. O. Tio, and N. M. Ali Long-Term Effects of Intracoronary {beta}-Radiation in Balloon- and Stent-Injured Porcine Coronary Arteries Circulation, April 24, 2001; 103(16): 2108 - 2113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wohlfrom, J. Kotzerke, J. Kamenz, M. Eble, B. Hess, J. Wohrle, S. N Reske, V. Hombach, H. Hanke, and M. Hoher Endovascular irradiation with the liquid {beta}-emitter Rhenium-188 to reduce restenosis after experimental wall injury Cardiovasc Res, January 1, 2001; 49(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cottin, M. Kollum, R. Chan, B. Bhargava, Y. Vodovotz, and R. Waksman Vascular repair after balloon overstretch injury in porcine model effects of intracoronary radiation J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1389 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Waksman, B. Bhargava, G. S. Mintz, R. Mehran, A. J. Lansky, L. F. Satler, A. D. Pichard, K. M. Kent, and M. B. Leon Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis J. Am. Coll. Cardiol., July 1, 2000; 36(1): 65 - 68. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |